SPC60
Vemurafenib og lyfjafræðilega ásættanleg sölt af því, í einhverju af því formi sem nýtur verndar í grunneinkaleyfinu
Status:
VeittApplication date:
13.6.2012Application published:
15.7.2012Grant published:
15.9.2012
Max expiry date:
20.2.2027Next due date:
30.6.2026Medicine name:
ZELBORAFMedicine for children:
No
Timeline
Today
13.6.2012Application
15.7.2012Publication
15.9.2012Registration
20.2.2027Expires
Marketing license
IS authorization number:
EU/1/12/751/001Date:
17.3.2012
Foreign authorization number:
EU/1/12/751/001Date:
17.2.2012
Owner
Name:
PLEXXIKON INC.Address:
91 Bolivar Drive, Suite A, Berkeley US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105 Reykjavík
Patent
Number:
EP1893612